Targeted drug combination shows unprecedented activity in some highly aggressive brain tumors

A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.

source https://medicalxpress.com/news/2021-11-drug-combination-unprecedented-highly-aggressive.html